Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 116,829.03%36.25K | 26,849.47%100.79K | 23,486.60%250.02K | 23,486.60%250.02K | -96.64%33 | -99.79%31 | -98.40%374 | -5.10%1.06K | -5.10%1.06K | -97.85%981 |
| -Cash and cash equivalents | 116,829.03%36.25K | 26,849.47%100.79K | 23,486.60%250.02K | 23,486.60%250.02K | -96.64%33 | -99.79%31 | -98.40%374 | -5.10%1.06K | -5.10%1.06K | -97.85%981 |
| Receivables | -42.52%10.42K | -50.85%8.49K | -62.58%5.87K | -62.58%5.87K | 23.27%19.56K | 50.40%18.13K | -67.28%17.27K | -68.56%15.69K | -68.56%15.69K | -72.38%15.87K |
| -Accounts receivable | --5.25K | --0 | --0 | --0 | --0 | --0 | --0 | -91.41%507 | -91.41%507 | -81.15%3.08K |
| -Taxes receivable | -71.48%5.17K | -50.85%8.49K | -61.33%5.87K | -61.33%5.87K | 52.91%19.56K | 80.79%18.13K | -63.76%17.27K | -65.50%15.18K | -65.50%15.18K | -68.90%12.79K |
| Prepaid assets | --831 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5K |
| Total current assets | 161.60%47.5K | 519.45%109.28K | 1,427.96%255.89K | 1,427.96%255.89K | -10.32%19.6K | -68.09%18.16K | -86.78%17.64K | -67.17%16.75K | -67.17%16.75K | -78.82%21.85K |
| Non current assets | ||||||||||
| Total non current assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total assets | 161.60%47.5K | 519.45%109.28K | 1,427.96%255.89K | 1,427.96%255.89K | -10.32%19.6K | -68.09%18.16K | -86.78%17.64K | -67.17%16.75K | -67.17%16.75K | -78.82%21.85K |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current liabilities | -2.70%321.98K | 18.00%323.85K | 76.49%413.23K | 76.49%413.23K | 100.73%384.67K | 133.98%330.91K | 214.62%274.45K | 122.15%234.14K | 122.15%234.14K | 107.50%191.64K |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -2.70%321.98K | 18.00%323.85K | 76.49%413.23K | 76.49%413.23K | 100.73%384.67K | 133.98%330.91K | 214.62%274.45K | 122.15%234.14K | 122.15%234.14K | 107.50%191.64K |
| Shareholders'equity | ||||||||||
| Share capital | 24.02%1.27M | 23.82%1.26M | 23.82%1.26M | 23.82%1.26M | -0.23%1.02M | -0.23%1.02M | -0.28%1.02M | 32.94%1.02M | 32.94%1.02M | 35.38%1.02M |
| -common stock | 24.02%1.27M | 23.82%1.26M | 23.82%1.26M | 23.82%1.26M | -0.23%1.02M | -0.23%1.02M | -0.28%1.02M | 32.94%1.02M | 32.94%1.02M | 35.38%1.02M |
| Additional paid-in capital | 0.00%91.2K | 0.00%91.2K | 0.00%91.2K | 0.00%91.2K | 0.00%91.2K | 0.00%91.2K | 0.00%91.2K | 13.89%91.2K | 13.89%91.2K | 4.25%91.2K |
| Retained earnings | -14.52%-1.63M | -14.83%-1.57M | -13.78%-1.51M | -13.78%-1.51M | -15.02%-1.48M | -18.84%-1.42M | -28.09%-1.37M | -47.32%-1.33M | -47.32%-1.33M | -54.26%-1.28M |
| Other equity interest | ---- | --2K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total stockholders'equity | 12.24%-274.48K | 16.44%-214.58K | 27.62%-157.34K | 27.62%-157.34K | -115.02%-365.08K | -270.00%-312.76K | -655.58%-256.81K | -299.75%-217.39K | -299.75%-217.39K | -1,669.07%-169.79K |
| Total equity | 12.24%-274.48K | 16.44%-214.58K | 27.62%-157.34K | 27.62%-157.34K | -115.02%-365.08K | -270.00%-312.76K | -655.58%-256.81K | -299.75%-217.39K | -299.75%-217.39K | -1,669.07%-169.79K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.